Drug and Alcohol Dependence

Papers
(The TQCC of Drug and Alcohol Dependence is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Signal of increased opioid overdose during COVID-19 from emergency medical services data310
The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017198
Alcohol and other substance use during the COVID-19 pandemic: A systematic review167
Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults149
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis103
Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK99
Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance96
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic93
The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review82
Adverse childhood experiences (ACEs) and substance use disorder (SUD): A scoping review82
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users79
Socioeconomic marginalization and opioid-related overdose: A systematic review78
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study71
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011–201668
The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder66
Non-pharmacological interventions for methamphetamine use disorder: a systematic review65
Contingency management for the treatment of methamphetamine use disorder: A systematic review63
Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A.63
Trends in LSD use among US adults: 2015–201862
Emotion regulation and substance use: A meta-analysis59
Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-201857
Alcohol and marijuana co-use: Consequences, subjective intoxication, and the operationalization of simultaneous use56
The relationship between incarceration history and overdose in North America: A scoping review of the evidence55
Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic55
Patterns of substance use among adolescents: A systematic review55
Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective54
Current reporting of usability and impact of mHealth interventions for substance use disorder: A systematic review54
Do men who have sex with men who report alcohol and illicit drug use before/during sex (chemsex) present moderate/high risk for substance use disorders?51
Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 202150
The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs49
Cocaine use and overdose mortality in the United States: Evidence from two national data sources, 2002–201849
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study48
Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 201948
Modes of marijuana use – smoking, vaping, eating, and dabbing: Results from the 2016 BRFSS in 12 States47
The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature46
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden46
Protracted renal clearance of fentanyl in persons with opioid use disorder45
Trends in drug use among electronic dance music party attendees in New York City, 2016–201944
Detecting fentanyl using point-of-care drug checking technologies: A validation study44
Trends in characteristics of individuals who use methamphetamine in the United States, 2015-201844
Transition from injecting opioids to smoking fentanyl in San Francisco, California44
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda44
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis44
Adolescent drug use before and during U.S. national COVID-19 social distancing policies43
Anabolic androgenic steroids, antisocial personality traits, aggression and violence43
Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization43
Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse42
Addressing opioid overdose deaths: The vision for the HEALing communities study42
Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups – United States, 2004–201941
The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland40
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-201739
Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder39
Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study39
Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study38
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine38
Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study37
Joint perceptions of the risk and availability of Cannabis in the United States, 2002-201837
Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty — United States, 2014–201937
Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004–201737
Imprecise action selection in substance use disorder: Evidence for active learning impairments when solving the explore-exploit dilemma37
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence37
Geographic proximity to buprenorphine treatment providers in the U.S.36
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an inte36
Recreational cannabis use impairs driving performance in the absence of acute intoxication36
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders36
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use35
Using machine learning for real-time BAC estimation from a new-generation transdermal biosensor in the laboratory35
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use34
Causal relationships between substance use and insomnia34
Community engagement to implement evidence-based practices in the HEALing communities study34
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic34
Associations between vaping and Covid-19: Cross-sectional findings from the HEBECO study33
Alcohol and substance use in pregnancy during the COVID-19 pandemic33
A systematic review of opioid overdose interventions delivered within emergency departments33
Cannabis labelling and consumer understanding of THC levels and serving sizes33
Prevalence and charges of opioid-related visits to U.S. emergency departments33
Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time33
The continued rise of methamphetamine use among people who use heroin in the United States32
The prevalence, child characteristics, and maternal risk factors for the continuum of fetal alcohol spectrum disorders: A sixth population-based study in the same South African community32
“I felt like I had a scarlet letter”: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain32
Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017-2018: A cross-sectional study32
Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio32
The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA31
Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs31
Genomic relationships across psychiatric disorders including substance use disorders30
Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review30
Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United State30
Common and distinct brain activity associated with risky and ambiguous decision-making30
Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems30
Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999–201830
Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism30
Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats30
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder30
LSD use in the United States: Trends, correlates, and a typology of us30
Longitudinal associations with alcohol consumption during the first COVID-19 lockdown: Associations with mood, drinking motives, context of drinking, and mental health29
Cannabis use during pregnancy in the United States: The role of depression29
Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia29
Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness29
Anabolic androgenic steroid dependence is associated with executive dysfunction29
Cannabis use among youth in the United States, 2004–2016: Faster rate of increase among youth with depression29
Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults28
Assessing alcohol consumption through wastewater-based epidemiology: Spain as a case study28
Shifts in drug seizures in the United States during the COVID-19 pandemic28
Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis28
Effects of multiple adverse childhood experiences on substance use in young adults: A review of the literature28
The cost of opioid use disorder and the value of aversion28
Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington28
Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status – 8 PRAMS states, 201727
Nicotine formulations impact reinforcement-related behaviors in a mouse model of vapor self-administration27
Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA27
Trust in a COVID-19 vaccine among people with substance use disorders27
Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence26
Association of transphobic discrimination and alcohol misuse among transgender adults: Results from the U.S. Transgender Survey26
Marijuana, but not alcohol, use frequency associated with greater loneliness, psychological distress, and less flourishing among young adults26
Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys26
Substance use improvement depends on Race/Ethnicity: Outpatient treatment disparities observed in a large US national sample26
Opioid use disorder treatment for people experiencing homelessness: A scoping review26
The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study26
Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose26
Drug checking identifies counterfeit alprazolam tablets26
Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose26
Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis25
How much and how fast: Alcohol consumption patterns, drinking-episode affect, and next-day consequences in the daily life of underage heavy drinkers25
Racial/ethnic differences in opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States, 1999−201725
How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis25
LGBTQ state policies: A lever for reducing SGM youth substance use and bullying25
Cross-fading motives for simultaneous alcohol and marijuana use: Associations with young adults’ use and consequences across days25
Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids25
Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use24
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder24
Legality of drug checking equipment in the United States: A systematic legal analysis24
Prevalence of substance use and substance-related disorders among US Veterans Health Administration patients24
Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic24
Risk and protective factors for repeated overdose after opioid overdose survival24
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD24
Effectiveness of the use of implementation intentions on reduction of substance use: A meta-analysis24
“It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health24
The state of the science in opioid policy research24
Changes in alcohol use since the onset of COVID-19 are associated with psychological distress among sexual and gender minority university students in the U.S23
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort23
Frequent teenage cannabis use: Prevalence across adolescence and associations with young adult psychopathology and functional well-being in an urban cohort23
Pregnant people’s experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabis23
Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic23
Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk23
Adolescent treatment admissions for marijuana following recreational legalization in Colorado and Washington23
Substance use disorders and risk of severe maternal morbidity in the United States23
Adherence to buprenorphine: An analysis of prescription drug monitoring program data23
Methamphetamine and Opioid Cue Database (MOCD): Development and Validation23
Predictive validity of the adult tobacco dependence index: Findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study23
Addressing long overdue social and structural determinants of the opioid epidemic22
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US22
Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: A systematic review22
Voluntary wheel running protects against the increase in ethanol consumption induced by social stress in mice22
Community dashboards to support data-informed decision-making in the HEALing communities study22
Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States22
A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth22
Gender, employment, and continuous pandemic as predictors of alcohol and drug consumption during the COVID-1921
Model and approach for assessing implementation context and fidelity in the HEALing Communities Study21
COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs21
Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012–201721
Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies21
COVID-19 survey among people who use drugs in three cities in Norway21
Use of telemedicine for opioid use disorder treatment – Perceptions and experiences of opioid use disorder clinicians21
Treatment provider perceptions of take-home methadone regulation before and during COVID-1921
Adolescent nicotine and marijuana vaping activity and the use of other illicit substances21
Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study21
Overdose and risk factors for coronavirus disease 201921
Race, pain, and opioids among patients with chronic pain in a safety-net health system20
Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report20
Gender differences in driving control of young alcohol-impaired drivers20
Mental and physical health in family members of substance users: A scoping review20
Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002–201920
An examination of the extent to which mood and context are associated with real-time alcohol consumption20
Review of sexualized drug use associated with sexually transmitted and blood-borne infections in gay, bisexual and other men who have sex with men20
Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users20
Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview20
Exposure and engagement with tobacco-related social media and associations with subsequent tobacco use among young adults: A longitudinal analysis20
Minority stress and drug use among transgender and gender diverse adults: A daily diary study20
The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose20
Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes20
Inpatient link to peer recovery coaching: Results from a pilot randomized control trial20
What is associated with the increased frequency of heavy episodic drinking during the COVID-19 pandemic? Data from the PAHO regional web-based survey20
Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers20
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 202020
Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting20
Impact of cannabis legalization in the United States on trends in cannabis use and daily cannabis use among individuals who smoke cigarettes20
Barriers and facilitators to PDMP IS Success in the US: A systematic review20
Retail availability and legal purchases of dried flower in Canada post-legalization19
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails19
Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis19
Use frequency and symptoms of nicotine dependence among adolescent E-cigarette users: Comparison of JUUL and Non-JUUL users19
Does e-cigarette experimentation increase the transition to daily smoking among young ever-smokers in France?19
Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis19
Measurement invariance and psychometric properties of Perceived Stigma toward People who use Substances (PSPS) among three types of substance use disorders: Heroin, amphetamine, and alcohol19
Canada’s cannabis legalization and drivers’ traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-201919
Alcohol expectancies change in early to middle adolescence as a function of the exposure to parental alcohol use19
Cross-country and historical variation in alcohol consumption among older men and women: Leveraging recently harmonized survey data in 21 countries19
Awareness, use and perceptions of cigarillos, heated tobacco products and nicotine pouches: A survey among Dutch adolescents and adults19
Healthcare stigma and HIV risk among rural people who inject drugs19
Trends in U.S. women’s binge drinking in middle adulthood by socioeconomic status, 2006–201819
Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England19
Testing the drug use and condomless anal sex link among sexual minority men: The predictive utility of marijuana and interactions with relationship status19
Evaluation of the rewarding effects of mitragynine and 7‐hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats19
Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments19
Tobacco use and tobacco services in California substance use treatment programs18
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults18
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states18
Tobacco and marijuana co-use in a cohort of young adults: Patterns, correlates and reasons for co-use18
Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature18
The prevalence and impact of elevated anxiety sensitivity among hazardous drinking college students18
Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year18
Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization18
Contexts of alcohol use: A latent class analysis among Argentinean college students18
Implementation and enforcement of state opioid prescribing laws18
Racial/ethnic discrimination and alcohol use disorder severity among United States adults18
Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats18
Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 201818
Associations of alcohol use, mental health and socioeconomic status in England: Findings from a representative population survey18
Impact of an unsanctioned safe consumption site on criminal activity, 2010–201918
Primary care physicians’ preparedness to treat opioid use disorder in the United States: A cross-sectional survey18
The impact of COVID-19 on opioid treatment programs in the United States18
Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California’s prescription drug monitoring program18
Digital media use and subsequent cannabis and tobacco product use initiation among adolescents18
Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children18
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program18
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial18
The use of person-centered language in scientific research articles focusing on alcohol use disorder17
Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials17
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws17
The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic17
Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006–201817
Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments17
Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats17
Trajectories of alcohol use and problems during the COVID-19 pandemic: The role of social stressors and drinking motives for men and women17
Predictors of marijuana vaping onset and escalation among young adults17
Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)17
Sociodemographic changes in emergency department visits due to alcohol during COVID-1917
Effect of alcohol interventions on suicidal ideation and behaviour: A systematic review and meta-analysis17
Syndemic latent transition analysis in the HPTN 061 cohort: Prospective interactions between trauma, mental health, social support, and substance use17
A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys17
Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York City17
“I cannot live without my vape”: Electronic cigarette user-identified indicators of vaping dependence17
Sexual minority tobacco use disparities across adolescence and the transition to young adulthood17
Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans17
Genome-wide association analysis of opioid use disorder: A novel approach using clinical data17
Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket17
Legal requirements and recommendations to prescribe naloxone17
Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States17
Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey17
Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity16
0.040549039840698